Agenda

Return

C. 44

To:	Board of Supervisors
From:	Anna Roth, Health Services Director
Date:	October 12, 2021

Contra

Costa

County

Subject:

Rescind Prior Board Action pertaining to the Amendment to Purchase Order with ASD Healthcare

APPROVE	OTHER
RECOMMENDATION OF CNTY ADMINISTRATOR	RECOMMENDATION OF BOARD COMMITTEE

Action of Board On: 10/12/2021

APPROVED AS RECOMMENDED

OTHER

Clerks Notes:

VOTE OF SUPERVISORS

AYE:

John Gioia, District I Supervisor
Candace Andersen, District II Supervisor
Diane Burgis, District III Supervisor
Karen Mitchoff, District IV Supervisor
Federal D. Glover, District V Supervisor

Contact:	Jaspreet Benepal, 925-370-5101
cc:	Irene Segovia Marcy Wilhelm

I hereby certify that this is a true and correct copy of an action taken and entered on the minutes of the Board of Supervisors on the date shown.
ATTESTED: October 12, 2021
Monica Nino, County Administrator

BY:	, Deputy

RECOMMENDATION(S):

RESCIND Board action of September 21, 2021 (C.50), which pertained to an amendment to a purchase order with ASD Healthcare; and APPROVE and AUTHORIZE the Purchasing Agent to execute, on behalf of the Health Services Department, an amendment to Purchase Order with ASD Healthcare to increase the payment limit by $500,000 for a new payment limit of $795,000 for the purchase of Remdesivir for Contra Costa Regional Medical Center patients with no change in the term of January 1, 2021 through December 31, 2021.

FISCAL IMPACT:

Approval of this purchase order amendment will result in $500,000 of additional annual expenditures and will be funded by 100% of the American Rescue Plan Act (ARPA) allocations.

BACKGROUND:

Contra Costa Regional Medical Center Pharmacy Department has been purchasing Remdesivir for the treatment of COVID-19 patients at Contra Costa Regional Medical Center from ASD Healthcare. ASD Healthcare is the only Federal Government authorized distributer.

BACKGROUND: (CONT'D)

On September 21, 2021, the Board of Supervisors approved amendment to Purchase Order with ASD Healthcare to add $300,000, which was the incorrect increase amount and was stated so due to an administrative error. The amount should have read to add $500,000 to a new total payment limit of $795,000. Approval of the correction will allow CCRMC to purchase enough Remdsivir for treatment of COVID-19 patients, through December 31, 2021.

CONSEQUENCE OF NEGATIVE ACTION:

If this contract is not approved, we will not be able to purchase Remdesivir which is needed for treating our COVID-19 patients causing a negative impact in the health of our patients at CCRMC.